| abstract |
The present invention relates to a nanocomposite comprising: a nano drug delivery system; and a ginseng extract or ginsenoside separated therefrom, and a method for producing the same. The nanocomposite can be used for the prevention or treatment of cancer and inflammatory diseases. The production time of the nanocomposite of the present invention is significantly reduced compared to conventional metal nanoparticles, and metal nanocomposites having a uniform size can be produced without the addition of a separate reducing agent or stabilizer. Also, the nanocomposite of the present invention has a high solubility in water and a high ability to target cancer cells, and thus is advantageous to be developed as a drug. In addition, the nanocomposite of the present invention exhibits high anti-cancer activity, anti-inflammatory activity, etc., and thus can be usefully utilized in the prevention and treatment of cancer and inflammatory diseases. Furthermore, the nanocomposite of the present invention has antibacterial activity, biofilm decomposition activity and anticoagulant activity, and thus can be utilized in various business fields. |